www.fdanews.com/articles/142875-regeneron-announces-settlement-with-genentech-for-u-s-sales-of-eylea

Regeneron Announces Settlement With Genentech for U.S. Sales of Eylea

January 3, 2012

Regeneron Pharmaceuticals announced that it has entered into a non-exclusive license and partial settlement agreement with Genentech relating to U.S. sales of Eylea (aflibercept) injection.
MarketWatch